BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 4872830)

  • 1. [Comparative studies of the diagnostic usefulness of the intracutaneous leukocyte test and antinuclear factors in chronic lupus erythematosus].
    Sönnichsen N
    Z Haut Geschlechtskr; 1967 Jun; 42(12):413-6. PubMed ID: 4872830
    [No Abstract]   [Full Text] [Related]  

  • 2. The immunofluorescent tumor imprint technic. 3. The diagnostic and prognostic significance of the "speckle"-inducing antinuclear antibody.
    Burnham TK; Neblett TR; Fine G
    Am J Clin Pathol; 1968 Dec; 50(6):683-8. PubMed ID: 4881946
    [No Abstract]   [Full Text] [Related]  

  • 3. The immunofluorescent tumor imprint technique. IV. The significance of "thready" nuclear immunofluorescence.
    Burnham TK; Neblett TR; Fine G; Bank P
    Arch Dermatol; 1969 May; 99(5):611-6. PubMed ID: 4889089
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin tests with nuclear factors in systemic lupus erythematosus.
    Jones HE; Derbes VJ; Gum OB; Azoury FJ
    Arch Dermatol; 1967 Jun; 95(6):559-64. PubMed ID: 5338435
    [No Abstract]   [Full Text] [Related]  

  • 5. [Significance of immunofluorescence in dermatology].
    Holubar K
    Z Haut Geschlechtskr; 1970 Feb; 45(3):113-20. PubMed ID: 4911829
    [No Abstract]   [Full Text] [Related]  

  • 6. [On some essential differences of scleroderma, dermatomyositis and acute lupus erythematosus and the variegated therapy based on them].
    Korting GW
    Dtsch Med Wochenschr; 1967 Feb; 92(7):281-8. PubMed ID: 6019059
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical cases and laboratory data in a group of mesenchymopathies: lupus erythematosus, dermatomyositis, scleroderma].
    Meneghini CL; Bonifazi E
    J Med Lyon; 1972 Sep; 53(232):1123-31. PubMed ID: 4539165
    [No Abstract]   [Full Text] [Related]  

  • 8. [Letter: Suitability of immunofluorescence technics for the diagnosis of bullous eruptions, lupus erythematosus, and certain other dermatoses].
    Holubar K; Stingl G
    Hautarzt; 1976 Jan; 27(1):30-9. PubMed ID: 767302
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antinuclear factors. Demonstration and clinico-diagnostic significance].
    Maas D
    Med Klin; 1969 Jul; 64(29):1302-7. PubMed ID: 4184549
    [No Abstract]   [Full Text] [Related]  

  • 10. [Baby hamster kidney cells as antigen for demonstration of antinuclear antibodies (author's transl)].
    Pernice W; Scherer R; Lüben G; Sodomann CP; Sedlacek HH
    Dtsch Med Wochenschr; 1978 Sep; 103(37):1448-53. PubMed ID: 308447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunological diagnosis of lupus erythematosus].
    Sönnichsen N; Barthelmes H; Meffert H; Albrecht-Nebe H; Diezel W; Günther W
    Dermatol Monatsschr; 1979 Oct; 165(10):708-20. PubMed ID: 393545
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunofluorescent studies in some autoimmune syndromes. I. Lupus erythematosus].
    Chorzelski T; Blaszczyk M
    Przegl Dermatol; 1971; 58(4):485-8. PubMed ID: 4938588
    [No Abstract]   [Full Text] [Related]  

  • 13. Antinuclear factors, rheumatoid factors and Bordet-Wassermann reaction in chronic and systemic lupus erythematosus.
    Strejcek J; Malina L; Bielický T
    Acta Derm Venereol; 1968; 48(3):198-202. PubMed ID: 4176741
    [No Abstract]   [Full Text] [Related]  

  • 14. [Value of the immunofluorescence method in the diagnosis of lupus erythematosus. Determination of antinuclear factor by means of plain nuclei of bird erythrocytes using Fischer's method].
    Vlasín Z; Horácek J; Lejhancová M
    Cesk Dermatol; 1968 Aug; 43(4):217-23. PubMed ID: 4175995
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of indirect immunofluorescence test by Weller and Coons for demonstration of antinuclear factors].
    Nebe H
    Dermatol Monatsschr; 1970 Oct; 156(10):913-8. PubMed ID: 4927926
    [No Abstract]   [Full Text] [Related]  

  • 16. Study of cutaneous lupus erythematosus by immunohistochemical methods.
    Pohle EL; Tuffanelli DL
    Arch Dermatol; 1968 May; 97(5):520-6. PubMed ID: 4171670
    [No Abstract]   [Full Text] [Related]  

  • 17. [Apropos of "borderline" connective tissue diseases. Visceral lupus and scleroderma].
    Cayla J; Saporta L; Delbarre F; Coste F
    Bull Mem Soc Med Hop Paris; 1967 Apr; 118(7):681-97. PubMed ID: 4170418
    [No Abstract]   [Full Text] [Related]  

  • 18. Systemic lupus erythematosus: antinuclear serology and cell-mediated immunity in the light of clinico-hematologic diagnostic criteria. Preliminary communication.
    Bitter T
    Schweiz Med Wochenschr; 1971 Feb; 101(6):181-6. PubMed ID: 4104947
    [No Abstract]   [Full Text] [Related]  

  • 19. Intradermal tests and antinuclear factors in systemic lupus erythematosus. A comparative study.
    Azoury FJ; Jones HE; Derbes VJ; Gum OB
    Ann Intern Med; 1966 Dec; 65(6):1221-8. PubMed ID: 5297139
    [No Abstract]   [Full Text] [Related]  

  • 20. [Determination of the antinuclear factors in lupus erythematosus].
    Sönnichsen N; Apostoloff G
    Dermatol Wochenschr; 1965 Jul; 151(30):880-3. PubMed ID: 5844784
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.